Affimed
AFMD
#11152
Rank
S$3.8 M
Marketcap
S$0.23
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

P/E ratio for Affimed (AFMD)

P/E ratio as of November 2026 (TTM): -0.0347

According to Affimed 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.034721. At the end of 2022 the company had a P/E ratio of -1.95.

P/E ratio history for Affimed from 2014 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.95-80.35%
2021-9.921.03%
2020-9.82100.16%
2019-4.91-39.19%
2018-8.07390.09%
2017-1.65-2.44%
2016-1.69-82.08%
2015-9.42-132.38%
201429.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Repligen
RGEN
-867 2,498,243.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-138 396,043.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
3.54-10,294.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-0.0676 94.71%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.